资源描述：
《New_Medicines_in_Development_for_Cancer__Part_I.22.pdf》由会员上传分享，免费在线阅读，更多相关内容在学术论文-天天文库。
1、PAGE58/SEPTEMBER10,2003NewMedicinesinDevelopmentforCancer:PartIhistableisadaptedandexcerptedfromthelatestPharmaceuticalprostatecancer,andselectedothersforkidney,pancreatic,brain,skin,ResearchandManufacturersofAmericasurveyofNewovarian,andothercancers,aswellasthos
2、edesignedtoimprovetheTMedicinesinDevelopmentforCancer.Asofthetimeofthequalityoflifeforpeopleundergoingcancertreatment.reportinMay,therewereatotalof395cancer-relatedmedicinesShownforeachitemarethenameoftheproduct,thecompany/inthepipeline,withresearchbeingconducted
3、by181pharmaceuticalorganizationinvolved,thecancerindication,thedevelopmentstatus,andbiotechnologycompaniesandtheNCI.Theseinclude70drugsforandacontacttelephonenumberwhenavailabletorequestfurtherinfor-lungcancer,49forbreastcancer,48forcolorectalcancer,and44formatio
4、n.Thetablewillcontinueinsubsequentissues.ProductNameCompanyIndicationDevelopmentStatusProductNameCompanyIndicationDevelopmentStatusBladderCancerpyrazoloacridineNCIglioblastomamultiforme,PhaseI/IIBethesda,MDglioma(seealsoNCITrialAdvexin®IntrogenTherapeutics(seeals
5、obrain,breast,PhaseIPfizerneuroblastoma)(800)422-6237(adenoviralp53)Austin,TXhead/neck,liver,lung,(512)708-9310NewYorkCityovarian,prostate)rebeccamycinNCI(seealsobreast,PhaseI/IIBCIImmuneIntracelResourcessuperficialbladderPhaseIIIanalogBethesda,MDliver,lung,NCITr
6、ialActivatorFrederick,MDcancerorcarcinoma(301)668-8400Exelixissolidtumors)(800)422-6237modifiedkeyholeinsitu(CIS)inpatientsSouthSanFranciscolimpetrefractorytoBCGhemocyanin(KLH)treatmentRSR13AllosTherapeuticsbrainmetastasesPhaseIII(efaproxiral)Westminster,CO(seeal
7、socervical,lung)(303)426-6262eflornithineILEXOncologysuperficialPhaseIII(DFMO)SanAntonio,TXbladdercancer(210)949-8200glioblastomaPhaseIImultiforme(303)426-6262galliummaltolateTitanPharmaceuticals(seealsolymphoma,PhaseI/IISouthSanFrancisco,CAmultiplemyeloma,(650)2
8、44-4990targetedtoxinsIVAXPhaseIIprostate)Miami(305)575-6000Levulan®PDDUSAPharmaceuticalsenhanceddetectionPhaseI/IItaxane(IV)BayerPharmaceuticalsbrainmetastases
